Accurate estimates of the prevalence of chronic hepatitis B virus (HBV) in the United States (US) are necessary for policy makers and community-based organisations to make informed decisions regarding the allocation of resources to work towards the elimination of HBV as a public health threat. The primary aim of this study was to quantify the […]
Despite global commitments to eliminate viral hepatitis by 2030, progress remains uneven. The Polaris Observatory tracks data from over 170 countries to evaluate hepatitis B (HBV) and C (HCV) elimination. While some nations have made significant strides—particularly in HCV treatment and HBV vaccination—few are on track to meet WHO’s full elimination targets. Barriers include complex […]
Summary Metabolic dysfunction-associated steatotic liver disease (MASLD), the most rapidly increasing and prevalent cause of chronic liver disease, is associated with substantial healthcare costs. As disease burden and costs mount, pharmacologic therapy which halts MASLD fibrosis progression is coming to fruition. Modeling the impact on disease progression of a hypothetical pharmacologic therapy which halts MASLD […]
English 
Spanish 
French 
Chinese 
Russian 
Arabic